CN Stock MarketDetailed Quotes

000403 Pacific Shuanglin Bio-pharmacy

Watchlist
  • 21.67
  • -0.09-0.41%
Market Closed Dec 13 15:00 CST
15.84BMarket Cap19.13P/E (TTM)

Pacific Shuanglin Bio-pharmacy Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacific Shuanglin Bio-pharmacy Q3 2024 Earnings Date

Currency：CNYOct 28, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
754.09M
--
+13.27%
EPS
--
0.30
--
--
Analyst Rating
Strong Buy

Dec 13, 2024

Pacific Shuanglin Bio-pharmacy Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1435.641M / 483.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1435.641M / 483.000M--

Pacific Shuanglin Bio-pharmacy Earnings Reports

  • Pailin Biotech: Report for the third quarter of 2024

    Oct 27 12:00 ET

  • Pailin Biotech: Earnings Forecast for the First Three Quarters of 2024

    Oct 9 12:00 ET

  • Pailin Biotech: 2024 Semi-Annual Report

    Aug 27 12:00 ET

  • Pailin Biotech: 2024 Semi-Annual Report Summary

    Aug 27 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Strong Buy

      95.46%

    • Buy

      4.55%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday-1.75%